Back to search

University of British Columbia

Extracellular granzyme B and pathophysiological implications

Abstract

dc:description

Granzyme B (GzmB) is a serine protease that contributes to immune-mediated elimination of cells by initiating a tightly-regulated form of death known as apoptosis. However, during inflammation, GzmB leaks out and accumulates in the extracellular space, retains its activity, and proficiently cleaves extracellular matrix (ECM) proteins. I therefore hypothesized that extracellular GzmB is capable of cleaving novel ECM substrates, contributing to dysregulated ECM integrity and function in disease. In the present dissertation I identified eleven novel extracellular GzmB substrates. Further investigations revealed that GzmB-mediated proteoglycan cleavage was implicated in the dysregulation of active transforming growth factorbeta (TGF-β) sequestration and bioavailability. GzmB cleavage sites were identified in biglycan and betaglycan and active TGF-β was shown to be released from decorin, biglycan and betaglycan. The pathophysiological role of my findings were further investigated and validated using animal models of disesase in which inflammation and elevated GzmB are observed. Evidence of fibrillin-1 and decorin cleavage were observed in atherosclerosis, abdominal aortic aneurysm and in skin aging pathogenesis. I also assessed the activity of GzmB in advanced atherosclerosis using perforin/apolipoprotein E- double knockout (Perf/apoE-DKO) and granzyme B/apolipoprotein E-double knockout (GzmB/apoE-DKO) mice. Interestingly, unlike our aneurysm findings whereby only GzmB/apoE-DKO mice were protected, both Perf/apoEDKO and GzmB/apoE-DKO mice were protected from atherosclerosis compared to apoE-KO controls, suggesting the intracellular Perf-dependent activities of granzymes are also important in the pathogenesis of atherosclerosis. In summary, GzmB is a protease that functions both intracellularly and extracellularly in disease. My findings suggest that the use of Perf knockout mice alone to study the role of GzmB in disease should be re-evaluated given the increasing evidence in both animal models and in human disease showing elevated GzmB in bodily fluids is associated with inflammation and age.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pathology and Laboratory Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Boivin, Wendy Anne

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/42827

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Boivin, Wendy Anne. Extracellular granzyme B and pathophysiological implications. doctoral thesis, University of British Columbia, 2012. http://hdl.handle.net/2429/42827